Lisbon, 2018-11-13 - NBE-Therapeutics was invited to present at CHI's 10th Annual PEGS Europe Protein & Antibody Engineering Summit

Roger Beerli, CSO of NBE-Therapeutics, and Rémy Gébleux, Scientist II, were invited to provide an update on NBE-Therapeutics' ADC development activities at CHI's 10th Annual PEGS Europe Protein & Antibody Engineering Summit in Lisbon.

NBE-Therapeutics was invited for two presentations at CHI's 10th Annual PEGS Europe Protein & Antibody Engineering Summit. Roger's presentation took place in the "Engineering" stream on Tuesday, Nov 13, 9:35 a.m. and was entitled "Direct Functional Screening for Antibody-Drug Conjugates Using Transpo-mAb Mammalian Cell Display". Rémy's presentation took place in the "Oncology" stream on Tuesday, Nov 13, 11:45 a.m. and was entitled "Preclinical Validation of Site-Specifically Conjugated ADCs with Potent Anthracycline Payloads in Solid and Hematologic Tumor Models".

All Meetings/ Conferences